Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data

• Glavni autori: Gils Roex (Autor), Tom Feys (Autor), Yves Beguin (Autor), Tessa Kerre (Autor), Xavier Poiré (Autor), Philippe Lewalle (Autor), Peter Vandenberghe (Autor), Dominique Bron (Autor), Sébastien Anguille (Autor)
• Format: Knjiga
• Izdano: MDPI AG, 2020-02-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Chimeric antigen receptor (CAR)-T-cell therapy is an innovative form of adoptive cell therapy that has revolutionized the treatment of certain hematological malignancies, including B-cell non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leukemia (ALL). The treatment is currently also being...